Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants

Author:

Pokorska-Śpiewak Maria12ORCID,Pawłowska Małgorzata3,Ciechanowski Przemysław4,Peregrym Michał4,Dobrzeniecka Anna2,Sobolewska-Pilarczyk Małgorzata3,Franczak Justyna3,Majda-Stanisławska Ewa5,Szczepańska Barbara6,Zaleska Izabela7,Flisiak Robert8

Affiliation:

1. From the Department of Children’s Infectious Diseases, Medical University of Warsaw, Warsaw, Poland

2. Department of Pediatric Infectious Diseases, Regional Hospital of Infectious Diseases in Warsaw, Warsaw, Poland

3. Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

4. Department of Pediatrics and Infectious Diseases, Regional Hospital in Szczecin, Szczecin, Poland

5. Department of Pediatric Infectious Diseases, Medical University of Lodz, Lodz, Poland

6. Department of Pediatrics, Pediatric Surgery and Otorhinolaryngology,Collegium Medicum Jan Kochanowski University, Kielce, Poland

7. Department of Pediatrics and Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland

8. Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.

Abstract

This study analyzed data for 1098 children: 575 diagnosed with COVID-19 between January and June 2022 (early Omicron) and 523 hospitalized from July 2022 to April 2023 (late Omicron). New Omicron subvariants lead to similar recovery rates without deaths and acute respiratory distress syndrome in children as BA.1 and BA.2, however, they more often cause fever and croup. Children suffering from comorbidities, presenting with pulmonary lesions and older, may be prone to a more severe consequences of COVID-19 in terms of the currently dominating Omicron subvariants.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3